Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep783 | Late Breaking | ECE2021

Cortisol measurement post steroids (Dexamethasone) treatment for COVID-19

Eltayeb Randa , Marwood Oliver , Kellam Shaun , Simpson Helen

IntroductionWe are currently mid Covid-19 pandemic. In the last year there have been 116, 135, 492 confirmed Covid-19 cases worldwide, with an estimated 2, 581, 976 deaths.The RECOVERY trial reported for patients hospitalized with Covid-19, the use of dexamethasone (6 mg for 10 days) resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxygen alone at randomisation. Adrenal ins...

ea0050p295 | Neuroendocrinology and Pituitary | SFEBES2017

Transitoin from paediatric to adult clinic in endocrinology: an assessment of experience at University College Hospital from the prospective of the adult service

Rosa Clementina La , Guardo Caterina Di , Simpson Helen , Conway Gerard , Moorthy Myuri , Baldeweg Stephanie

Background: Transition from paediatric to adult services is a crucial process for young adults with long term conditions (LTC) affecting quality of life and engagement with medical services. The recent NICE report has outlined overarching principles for an effective transition. This can be a challenge for paediatricians and adult physicians as both hospital sites and medical/nursing teams can change. There is a dearth of evidence regardin...

ea0050p295 | Neuroendocrinology and Pituitary | SFEBES2017

Transitoin from paediatric to adult clinic in endocrinology: an assessment of experience at University College Hospital from the prospective of the adult service

Rosa Clementina La , Guardo Caterina Di , Simpson Helen , Conway Gerard , Moorthy Myuri , Baldeweg Stephanie

Background: Transition from paediatric to adult services is a crucial process for young adults with long term conditions (LTC) affecting quality of life and engagement with medical services. The recent NICE report has outlined overarching principles for an effective transition. This can be a challenge for paediatricians and adult physicians as both hospital sites and medical/nursing teams can change. There is a dearth of evidence regardin...

ea0065cmw2.2 | Hyperparathyroidism | SFEBES2019

Genetic testing in hyperparathyroidism – who to test and why

Mariathasan Sashi , Andrews Katrina , Thompson Edward , Armstrong Ruth , Simpson Helen , Casey Ruth , Park Soo-Mi

Primary hyperparathyroidism (PHPT) is a common endocrine disorder with a prevalence of 0.86% in Europe. Approximately 10% of cases are hereditary. Syndromic PHPT occurs as part of multiple endocrine neoplasia (MEN)1, MEN4, MEN2A and hyperparathyroidism jaw tumour syndrome. Non-syndromic causes include familial hypocalciuric hypercalcaemia. Establishing the underlying genetic cause allows for targeted, cost effective management. Current guidelines recommend that genetic testing...

ea0065p142 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer | SFEBES2019

Living with and beyond childhood cancer – endocrine impact up to 40 years on

Surandran Sanggeeta , Idama Ella , Windsor Rachael , Davies Melanie , Grandage Victoria , Simpson Helen

Objective: To review impact of childhood cancer treatment on endocrine, gonadal and thyroid function.Methods: Retrospective review of electronic records of 79 females, 90 males over 6 months of clinic visits from a Late Effects of childhood cancer clinic. Age at diagnosis: 8.5 years (range 5 months–9 years); time from treatment 23.5 years (range 10–40). Diagnoses: ALL, AML, Hodgkin’s lymphoma, Non-Hodgkin’s lymphoma, sarcomas, Wilms, ...

ea0065p371 | Reproductive Endocrinology and Biology | SFEBES2019

Polycythaemia in a Klinefelter syndrome population on testosterone

Palan Jessal Mitul , Chung Teng-Teng , Simpson Helen , Baldeweg Stephanie , Srirangalingam Umasuthan

Background: Klinefelter syndrome (KS), karyotype 47XXY, affects 1 in 650 males. Subjects develop primary gonadal failure requiring life-long testosterone replacement. Many different testosterone formulations are available and long-term monitoring is necessary to avoid secondary polycythaemia.Objective: To investigate the effect of testosterone formulations used in KS subjects and estimate frequency of association with secondary polycythaemia.<p class...

ea0044p126 | Neoplasia, cancer and late effects | SFEBES2016

Radiological surveillance in multiple endocrine neoplasia type 1: A double edged sword?

Casey Ruth , Saunders Debbie , Challis Ben , Pitfield Deborah , Cheow Heok , Shaw Ashley , Simpson Helen

Multiple endocrine neoplasia type 1 (MEN1) is a hereditary condition characterised by the predisposition to hyperplasia or the development of solitary adenomas of multiple endocrine gland. MEN1 related disease is responsible for death in two thirds of patients with this hereditary condition and the mean age at death is 55 years. This associated mortality necessitates a vigorous surveillance protocol, however all recommendations for radiological surveillance are based on non-pr...

ea0038oc5.3 | Thyroid and parathyroid | SFEBES2015

Use of 11C-methionine PET to localise parathyroid adenoma/hyperplasia: a single centre experience

Challis Ben , Saad Ziauddin , Cheow H K , Buscombe John , Simpson Helen

Introduction: It is established practice to localise parathyroid lesions preoperatively using ultrasound (US) and sestaMIBI (MIBI). Whilst these imaging techniques have good sensitivity/specify, there are patients in which imaging does not localise a parathyroid lesion. 11C-Methionine PET (MET PET) is an imaging modality where 11C-methionine, a radioactive tracer, is taken up at sites of protein/peptide synthesis and has been demonstrated to be effective ...

ea0031p151 | Neoplasia, cancer and late effects | SFEBES2013

Phenotype–genotype analysis in a cohort of patients with multiple endocrine neoplasia type 1 identifies a novel nonsense mutation at codon 554

Reddy Snigdha , Goudie Calum , Parker Victoria , Park Soo-Mi , Treacy Becky , Simpson Helen

Aims: MEN1 is characterised by parathyroid, pituitary and pancreatic tumours in association with neoplasia of intra-thoracic endocrine tissue, adrenal glands and cutaneous manifestations. Mutations of the tumour suppressor Menin are causative and affected patients possess heterozygous germline mutations in MEN1, with acquisition of a second hit in the wild-type allele initiating tumourigenesis. Phenotype–genotype correlations can provide insights into the molecular functi...

ea0028p250 | Pituitary | SFEBES2012

Factors affecting growth hormone (GH) replacement during transition in patients with childhood-onset GH deficiency

Thankamony Ajay , Capalbo Donatella , Rachel Williams , Heywood James , Ong Ken , Dunger David , Simpson Helen

Background: GH therapy during the transition period is important for somatic maturation. Identification of factors associated with low IGF-I levels may be useful in optimising GH replacement therapy.Objectives: To explore the prevalence and determinants of insufficient GH replacement during transitionMethods: Childhood-onset GH deficient (CO-GHD) patients (n=65) who stopped therapy, and were started on adult GH dose during t...